|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Mr. Gaetan Waucquez||CEO, MD of Chemicals Division, Member of Management Board & Director||358,82k||N/D||N/D|
|Mr. LoÃ¯c Waucquez||MD and Non-Exec. & Shareholder Representative Director||18,5k||N/D||N/D|
|Mr. Thibaut Hofman||Chief Financial Officer||N/D||N/D||N/D|
|Mr. Joseph De Waele||Mang. of Accounting Department||N/D||N/D||N/D|
|Mr. Christian van Osselaer||Managing Director of Life Sciences Division||N/D||N/D||N/D|
|Mr. Philippe-Jean Boonen||Managing Director of Gourmet Food Division||N/D||N/D||N/D|
Floridienne S.A., through its subsidiaries, operates in the specialty chemicals and recycling, gourmet food, and life sciences sectors in Belgium. The company's Chemicals division offers plastic additives that are used for stabilizing PVC and fireproofing plastics; and recycles nickel/cadmium, nickel-metal hybrid, and lithium-ion rechargeable batteries, as well as zinc salts for galvanization. This division is also involved in the formulation and production of calcium/zinc-based and organic stabilizers. Its Gourmet Food division produces and markets party and gourmet food products, such as snails, scallops, stuffed shellfish, smoked salmon, seafood salads, flaky pastry appetizers, prepared ethnic dishes, cold and warm sauces, vinegars, condiments, jams, and spreads. This division also operates in the field of specialized foods for people with deglutition problems. The company's Life Sciences division produces and markets natural technologies and products for agriculture, agri-foodstuff, health care, para pharmaceutical, and cosmetics industries, as well as provides plant proteases and integrated pest management. This division also invests in solutions, such as chemical communication through receptors associated with taste and olfaction in mammals. Floridienne S.A. was founded in 1898 and is based in Waterloo, Belgium.
L'ISS Governance QualityScore di Floridienne S.A. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.